Share chart Synlogic, Inc.
Extended chart
Simple chart
About Synlogic, Inc.
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the United States. more detailsMain settings
| IPO date | 2015-10-01 |
|---|---|
| ISIN | US87166L1008 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | link |
| Change price per day: | -0.5217% (1.15) |
|---|---|
| Change price per week: | +2.72% (1.1137) |
| Change price per month: | -0.5217% (1.15) |
| Change price per 3 month: | -18.29% (1.4) |
| Change price per half year: | -19.15% (1.415) |
| Change price per year: | -27.13% (1.57) |
| Change price per 3 year: | +4.95% (1.09) |
| Change price per 5 year: | -48.24% (2.21) |
| Change price per year to date: | -17.7% (1.39) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | 2134.34 | 1 |
| P/BV | 1.34 | 9 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -48.98 | 0 |
| ROE, % | -84.32 | 0 |
| ROIC, % | 0 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.7831 | 10 |
| Debt/Ratio | 0.8713 | 9 |
| Debt/Equity | 0.5549 | 9 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | -98.53 | 0 |
| Yield Ebitda, % | -63.54 | 0 |
| Yield EPS, % | 21.22 | 4 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| NEA Management Company, LLC | 2 922 774 | 25.09 |
| Armistice Capital, LLC | 1 055 000 | 9.06 |
| FMR, LLC | 258 644 | 2.22 |
| Vanguard Group Inc | 188 433 | 1.62 |
| Alyeska Investment Group, L.P. | 55 872 | 0.48 |
| Renaissance Technologies, LLC | 54 630 | 0.47 |
| Geode Capital Management, LLC | 44 423 | 0.38 |
| Harbor Capital Advisors, Inc. | 30 685 | 0.26 |
| Fiduciary Trust Company (MA) | 22 352 | 0.19 |
| Ikarian Capital, LLC | 20 448 | 0.18 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Antoine Awad | Principal Executive Officer | 580.33k | 1980 (45 years) |
| Dr. Timothy K. Lu M.D., Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | 1981 (44 years) |
| Dr. James J. Collins Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | 1966 (59 years) |
| Ms. Mary Beth Dooley | VP, Head of Finance and Principal Financial Officer & Principal Accounting Officer | N/A | 1981 (44 years) |
| Mr. Ajay Munshi | Vice President of Corporate Development | N/A | |
| Ms. Molly Harper | Chief Business Officer | N/A | 1977 (48 years) |
| Dr. Neal Sondheimer M.D., Ph.D. | VP & Head of Clinical | N/A | |
| Dr. Mylene Perreault Ph.D. | VP & Head of Research | ||
| Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Advisor | 1962 (63 years) |
About company
Address: United States, Cambridge. MA, 301 Binney Street - Open in google maps, Open in yandex maps
Website: https://www.synlogictx.com
Website: https://www.synlogictx.com
